All Stories

  1. IFN-?, but not IL-17A, is required for survival during secondary pulmonary Francisella tularensis Live Vaccine Stain infection
  2. Identification of Early Interactions between Francisella and the Host
  3. Infection with Francisella tularensis LVSclpBLeads to an Altered yet Protective Immune Response
  4. Identification of T-cell epitopes in Francisella tularensis using an ordered protein array of serological targets
  5. Islet lymphocyte subsets in male and female NOD mice are qualitatively similar but quantitatively distinct
  6. Identification of a dominant CD4 T cell epitope in the membrane lipoprotein Tul4 from Francisella tularensis LVS
  7. Novel epitope begets a novel pathway in type 1 diabetes progression
  8. Outsmarting the host: bacteria modulating the immune response
  9. Neues Buch: Immunodominance – The Choice of the Immune System. Von Jeffrey A. Frelinger (Hrsg.)
  10. Immunodominance
  11. Adoptive transfer of E. faecalis-pulsed dendritic cells accelerates colitis in IL-10 deficient mice
  12. Mechanisms of Unresponsiveness:T- And B-Cell Mediated Mechanisms of Anergy
  13. Analysis of the mutant HLA-A∗0201 heavy chain H74L: impaired TAP-dependent peptide loading
  14. Altered peptide ligand design: altering immune responses to class I MHC/peptide complexes
  15. H2 Class I
  16. Immune Response of β2-Microglobulin-Deficient Mice to Pathogens
  17. The Role of Peptide Specificity in MHC Class I‐Restricted Allogeneic Responses
  18. The Cell‐Mediated Immune Response Against Lymphocytic Choriomeningitis Virus in β2‐microglobulin Deficient Mice
  19. BURN INJURY IMPAIRS SECOND-SET REJECTION AND CTL REACTIVITY IN MICE PRIMED BY CULTURED KERATINOCYTE ALLOGRAFTS
  20. Alterations of a dominant epitope of lymphocytic choriomeningitis virus which affect class I binding and cytotoxic T cell recognition
  21. Different MHC class I alleles compete for presentation of overlapping viral epitopes
  22. CULTURED MOUSE KERATINOCYTE ALLOGRAFTS PRIME FOR ACCELERATED SECOND SET REJECTION AND ENHANCED CYTOTOXIC LYMPHOCYTE RESPONSE1,2
  23. Restoration of CTL recognition of a mutant FMP peptide by a compensatory change in HLA-A2
  24. CULTURED MOUSE KERATINOCYTE ALLOGRAFTS PRIME FOR ACCELERATED SECOND SET REJECTION AND ENHANCED CYTOTOXIC LYMPHOCYTE RESPONSE1,2
  25. Transfer of lymphocytic choriomeningitis disease in β 2 -microglobulin-deficient mice by CD4 + T cells
  26. Production and Characterization of Two New Mouse Monoclonal Antibodies Reactive with Denatured Mouse Class II Beta Chains
  27. Clonal Analysis of Peripheral T Cell Precursors in Ipr Mice
  28. Structure function analysis of theH-2 Ab p gene
  29. Production and characterization of a peptide specific, anti-major histocompatibility complex class II, monoclonal antibody
  30. Detergent enhances binding of a secreted HLA-A2 molecule to solid phase peptides
  31. Analysis of novel residues of class I involved in recognition by alloreactive T cells
  32. Mutations in the α1 domain of a class I gene define residues important for specific allorecognition
  33. Differential transport requirements of HLA and H-2 class I glycoproteins
  34. Signaling to a B-cell clone by Ek, but not Ak, does not reflect alteration of A k genes
  35. Gene regulation, organization and function
  36. The ?1 and ?2 domains of H-2 class I molecules interact to form unique epitopes
  37. The expression and detection of MHC class I antigens on murine neuroblastoma and ependymoblastoma lines
  38. The Class II Molecule as a Signal Transducer to the B Cell: Cellular and Molecular Approaches
  39. A new murine lymphocyte alloantigen, Ly-27.2
  40. Perspectives in immunogenetics and histocompatibility volume 6: Lymphocyte surface antigens 1984
  41. Immunogenetic Approaches to Cell Surface Molecules in the Mouse
  42. Functional characterization of the H-2Dp gene product
  43. Cloning and identification of the H-2D p gene
  44. Antigenic relationships of murine coronaviruses: Analysis using monoclonal antibodies to JHM (MHV-4) virus
  45. LOW-DENSITY MONONUCLEAR CELLS
  46. Monoclonal antibodies reactive with H-2 determinants
  47. Brain Ia antigens have a bone marrow origin
  48. Ia antigens on non-lymphoid tissues their origins and functions
  49. BONE MARROW-DERIVED CELLS ARE RESPONSIBLE FOR STIMULATING I REGION-INCOMPATIBLE SKIN GRAFT REJECTION
  50. Peptide map comparisons of epidermal and spleen H-2 molecules
  51. Tryptic peptide map analyses of mouse transplantation antigens
  52. Macrophages and Resistance to JHM Virus CNS Infection
  53. Bone Marrow Origin of Ia Molecules Purified from Epidermal Cells
  54. GENETIC CONTROL OF RESISTANCE OF MOUSE HEPATITIS VIRUS, STRAIN JHM, INDUCED ENCEPHALOMYELITIS
  55. GENETIC CONTROL OF RESISTANCE TO JHM, A NEUROTROPIC STRAIN OF MOUSE HEPATITIS
  56. Mouse epidermal Ia molecules have a bone marrow origin
  57. Epidermal Ia molecules from theI-A andI-EC subregions of the mouseH-2 complex
  58. Resistance to fatal central nervous system disease by mouse hepatitis virus, strain JHM
  59. EVIDENCE FOR T SUPPRESSOR CELL FUNCTION IN A THYMUS INDEPENDENT MITOGENIC RESPONSE TO LIPOPOLYSACCHARIDE
  60. A new alloantigen, Ly-8, recognized by C3H anti-AKR serum
  61. A cautionary note regarding Ia andH-2 typing of murine lymphoid tumors
  62. The relationship of the major murine histocompatibility region associated IA antigens to mitogen responses
  63. The distribution of la antigens of the H-2 complex on lymph node cells by immunoferritin labelling
  64. Transferrin Polymorphism and Hardy-Weinberg Ratios
  65. Chemical basis of transferrin polymorphism in pigeons
  66. Synthesis and conservation of ribosomal RNA in adult mosquito ovaries